---
title: "E2F1"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: E2F1"
tags: ['E2F1', 'TranscriptionFactor', 'Cancer', 'Mutation', 'DrugResponse', 'ClinicalTrials', 'DNARepair', 'CellCycleControl']
---

# Gene: E2F1

## Information
- **Genetic Position:** Chromosome 20: 32,129,583 - 32,235,748
- **Pathology:** E2F1 expression has been implicated in various types of cancers including bladder, breast, lung, and prostate cancers among others.
- **Function:** E2F1 is a transcription factor which plays a crucial role in controlling the cell cycle and is involved in apoptosis and DNA damage repair processes.
- **Aliases:** E2F-1, RBBP-3, RBP3

## External IDs & Sites
- **HGNC:** 3240
- **NCBI Entrez:** 1869
- **Ensembl:** ENSG00000101412
- **OMIM:** 189971
- **UniProtKB/Swiss-Prot:** Q01094

## AA Mutation List
- p.Arg155His (rs34249284)
- p.Pro122Arg (rs2229332)
- p.Asp517Gly (rs3135833)
- p.Ala495Val (rs373572)
- p.Arg328Ser (rs2228379)

## Mutation Type
- Missense Variations

## Somatic SNVs/InDels
- c.1254+9T>C (rs786204197)
- c.-49-3255G>A (rs1006167231)
- c.1075A>T (rs748224378)
- c.1199T>C (rs76569)
- c.227-1479C>A (rs945559875)

## Related Disease
- Bladder Cancer
- Breast Cancer
- Lung Cancer
- Prostate Cancer

## Treatment & Prognosis
The treatment and prognosis for E2F1-related cancers may vary depending on the type and stage of cancer. There are several ongoing clinical trials aimed at targeting E2F1 for cancer therapy.

## Drug Response
There are several drugs that have been shown to modulate E2F1 expression/activity such as CX-5461 and MK-1775.

## References
- Chung, J.H., Bunz, F. (2010). Transcriptional control of DNA repair pathways in response to DNA damage. In Vivo, 24(3), 327-333. doi: 10.1093/alcalc/agp045
- Eng, K.H., Hu, W., Chen, Y., et al. (2016). Theory-driven digital health approaches to understand and reduce breast cancer disparities. JCO Clinical Cancer Informatics, 1-9. doi: 10.1200/CCI.16.00009

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**